Maertens Pharma Associes SRL
2.5 FTEMaertens Pharma Associes reported total assets of 583,944 € at the end of the 2025 financial year (annual accounts filed with the NBB on 29 Jun 2026), with 2.5 full-time equivalents.
The score of Maertens Pharma Associes shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +6 % Total assets -18 % Headcount (avg FTE) -11 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Maertens Pharma Associes's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 1,154 € | ||||
| Equity | 344,243 € | ||||
| Cash | 79,448 € | ||||
| EBITDA | 82,338 € | ||||
| Total assets | 583,944 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Jun 2026
- Year ended 31 Dec 2024filed on 21 Aug 2025
- Year ended 31 Dec 2023filed on 19 Jun 2024
- Year ended 31 Dec 2022filed on 20 Jun 2023
- Year ended 31 Dec 2021filed on 30 Jun 2022
Maertens Pharma Associes's financial analysis
- Solvency59.0%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Maertens Pharma Associes
Maertens Pharma Associes's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0821.407.282
- VAT number
- BE0821407282
- Peppol
- Registered · 0208:0821407282 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 14 Dec 2009
- Registered office
- 6460 Chimay
- Size
- Micro · 2.5 FTE
- Latest accounts
- 2025 · filed on 29 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Maertens Pharma Associes (SRL) has been based in Chimay since 2009, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 1,154 € and equity of 344,243 €; its revenue is not published. With 2.5 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 59.0%, above the median of its sector (41.5%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Maertens Pharma Associes
Companies in the same business, of comparable size and area, outside its group.
- Eeuwfeestapotheek Retail sale of pharmaceutical products Antwerp · balance sheet 583,835 €
- Beirnaert VG Retail sale of pharmaceutical products Destelbergen · balance sheet 584,335 €
- Pharmacie de Jalhay Retail sale of pharmaceutical products Chaudfontaine · balance sheet 584,400 €
- Apotheek Suys Retail sale of pharmaceutical products Laarne · balance sheet 583,450 €
- Medipharm Retail sale of pharmaceutical products Evere · balance sheet 583,033 €
- Pharmax Retail sale of pharmaceutical products Liège · balance sheet 586,278 €
- Belpharma Retail sale of pharmaceutical products Namur · balance sheet 581,313 €
- Farmafleur Retail sale of pharmaceutical products Antwerp · balance sheet 542,076 €
Frequently asked questions about Maertens Pharma Associes
What is the revenue of Maertens Pharma Associes?
Maertens Pharma Associes files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Maertens Pharma Associes?
In Belgium, the VAT number is the company number prefixed with BE: BE0821407282 for Maertens Pharma Associes, if the company is VAT-registered. Its company number (CBE) is 0821.407.282.
Where is the registered office of Maertens Pharma Associes?
According to the CBE register, the registered office of Maertens Pharma Associes is in 6460 Chimay.
What is the equity of Maertens Pharma Associes?
At the close of the 2025 financial year, the equity of Maertens Pharma Associes amounts to 344,243 €, a solvency of 59.0% of total assets.
How many people work at Maertens Pharma Associes?
2.5 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Maertens Pharma Associes?
The register lists 1 active mandates at Maertens Pharma Associes. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Maertens Pharma Associes
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →